ANVS (Annovis Bio, Inc.)

Insider Trading Activity

Every open-market purchase and sale reported by ANVS officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Form 4 Filings
50
most recent
Open-Market Buys
9
code P
Sales
0
code S
Reporting Insiders
9
current holders
ANVS — Recent Form 4 Transactions (latest 2026-05-21)
FiledInsiderRole TypeSharesValue
2026-05-21 Michael B Hoffman Director Buy
2026-04-03 Michael B Hoffman Director Buy
2025-12-08 Michael B Hoffman Director Buy
2025-11-25 Michael B Hoffman Director Buy
2025-11-25 Michael B Hoffman Director Buy
2025-11-21 Michael B Hoffman Director Buy
2025-11-18 Michael B Hoffman Director Buy
2025-11-12 Michael B Hoffman Director Buy
2025-11-12 Maria-Luisa Maccecchini President & CEO Buy
2025-11-12 Claudine Bruck Director M
2025-09-03 Michael B Hoffman Director A
2025-08-20 Michael B Hoffman Director A
2025-06-18 Andrew Walsh Vice President, Finance A
2025-06-16 Michael B Hoffman Director A
2025-06-11 Reid McCarthy Director A
2025-06-05 Maria-Luisa Maccecchini President & CEO A
2025-06-02 Michael B Hoffman Director A
2024-07-03 Michael B Hoffman Director A
2024-07-03 Reid McCarthy Director A
2024-07-03 Mark K. White Director A
2024-07-03 Maria-Luisa Maccecchini President and CEO G
2024-07-03 Claudine Bruck Director A
2023-11-22 Maria-Luisa Maccecchini President and CEO A
2023-11-22 Mark K. White Director A
2023-11-22 Henry Hagopian III Chief Financial Officer A
2023-11-22 Reid McCarthy Director J
2023-11-22 Michael B Hoffman Director A
2023-11-22 Claudine Bruck Director J
2023-11-21 Mark K. White Director A
2023-11-21 Michael B Hoffman Director A
2023-11-21 Maria-Luisa Maccecchini President and CEO A
2023-11-21 Reid McCarthy Director A
2023-11-21 Claudine Bruck Director A
2023-11-21 Henry Hagopian III Chief Financial Officer A
2023-04-26 Maria-Luisa Maccecchini President and CEO G
2023-04-11 Mark K. White Director A
2023-04-11 Maria-Luisa Maccecchini President and CEO A
2023-04-11 Henry Hagopian III Chief Financial Officer A
2023-04-11 Michael B Hoffman Director A
2023-04-11 Reid McCarthy Director A
2023-04-11 Claudine Bruck Director A
2023-02-08 Maria-Luisa Maccecchini President and CEO M
2023-01-20 Claudine Bruck Director A
2023-01-20 Mark K. White Director A
2023-01-20 Michael B Hoffman Director A
2023-01-20 Maria-Luisa Maccecchini President and CEO A
2023-01-20 Henry Hagopian III Chief Financial Officer A
2023-01-20 Reid McCarthy Director A
2022-08-31 Henry Hagopian III Chief Financial Officer A
2022-01-18 Maria-Luisa Maccecchini President and CEO M
ANVS — Current Insider Holders
InsiderRole Shares HeldValue
Director 3,514,458
President & CEO 1,212,020
Director 95,700
Director 61,167
Chief Financial Officer 52,669
Director 13,709
Director 9,305
Chief Financial Officer 1,820
Vice President, Finance 500
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the ANVS quote page; the site-wide leaderboard is on the insider transactions hub.